Who owns SINGULAR GENOMICS SYSTEMS IN?
- Ticker: OMIC
- CUSIP Number: 82933r100
Tip: Access positions for across all investors
Analyze quarterly positions in Singular Genomics Systems In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Singular Genomics Systems In stock
Who bought or sold SINGULAR GENOMICS SYSTEMS IN this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 5.0M | $2.6M | 0% | Mar 2024 |
|
| Arch Venture Corp | 3.8M | $2.0M | 0% | Mar 2024 |
|
| UBS Group | 2.2M | $1.1M | 0% | Mar 2024 |
|
| Perceptive Advisors | 2.1M | $1.1M | 0% | Mar 2024 |
|
| FMR | 2.1M | $1.1M | 0% | Mar 2024 |
|
| Vanguard Group | 1.9M | $963k | 0% | Mar 2024 |
|
| Casdin Capital | 1.3M | $681k | 0% | Mar 2024 |
|
| BlackRock | 739k | $380k | -15% | Mar 2024 |
|
| OrbiMed Advisors | 541k | $278k | 0% | Mar 2024 |
|
| HighTower Advisors | 528k | $272k | 26% | Mar 2024 |
|
| Verition Fund Management | 500k | $257k | 5% | Mar 2024 |
|
| Geode Capital Management | 461k | $237k | 0% | Mar 2024 |
|
| Triatomic Management | 195k | $100k | 0% | Mar 2024 |
|
| Millennium Management | 176k | $91k | 49% | Mar 2024 |
|
| Citadel Advisors | 130k | $67k | 175% | Mar 2024 |
|
| Bridgeway Capital Management | 122k | $63k | -56% | Mar 2024 |
|
| Squarepoint Ops | 102k | $52k | -15% | Mar 2024 |
|
| Northern Trust | 80k | $41k | 0% | Mar 2024 |
|
| Christopher Weil & Company | 68k | $35k | -51% | Mar 2024 |
|
| Susquehanna International | 51k | $26k | 100% | Mar 2024 |
|
| Marino, Stram & Associates | 40k | $21k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 39k | $20k | -25% | Mar 2024 |
|
| DLK Investment Management | 25k | $13k | 0% | Mar 2024 |
|
| XTX Topco | 25k | $13k | 100% | Mar 2024 |
|
| Goldman Sachs Group | 22k | $11k | 5% | Mar 2024 |
|
| Engineers Gate Manager | 15k | $7.7k | 0% | Mar 2024 |
|
| Palumbo Wealth Management | 13k | $6.5k | 100% | Mar 2024 |
|
| Barclays | 12k | $6.0k | 0% | Mar 2024 |
|
| Bank of America Corporation | 11k | $5.5k | 0% | Mar 2024 |
|
| Morgan Stanley | 8.7k | $4.5k | -37% | Mar 2024 |
|
| Tower Research Capital | 6.0k | $3.1k | -82% | Mar 2024 |
|
| Royal Bank of Canada | 2.0k | $1.0k | -29% | Mar 2024 |
|
| Dynamic Wealth Strategies | 1.7k | $999.940000 | 100% | Mar 2024 |
|
| Rhumbline Advisers | 1.7k | $853.935600 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 682.00 | $351.025400 | -93% | Mar 2024 |
|
| Wells Fargo & Company | 384.00 | $196.992000 | 2% | Mar 2024 |
|
| Harbour Investments | 172.00 | $78.999600 | 0% | Dec 2023 |
|
| Citigroup | 29.00 | $14.998800 | 0% | Mar 2024 |
|
Who sold out of Singular Genomics Systems In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank Of Montreal | Dec 2023 | 983k | $481k |
| Platinum Investment Mangement | Sep 2023 | 427k | $163k |
| Cambridge Investment Research Advisors | Dec 2023 | 26k | $12k |
| Bank of New York Mellon | Dec 2023 | 26k | $12k |
| Bay Rivers Group | Dec 2023 | 14k | $6.4k |
| Two Sigma Securities | Dec 2023 | 13k | $5.8k |
| Dagco | Dec 2023 | 1.7k | $782.000000 |
| Simplex Trading | Dec 2023 | 522.00 | $0 |